Mark Baer

1.5k citations

23 papers · 1.3k indexed · h-index 15

Immunology top 5%
- Immune Response and Inflammation 7
- Immune cells in cancer 3
Cancer Research top 10%
- NF-κB Signaling Pathways 6
Hematology top 10%
- Acute Myeloid Leukemia Research 3
Molecular Medicine top 10%
Genetics top 10%
Oncology
- Cytokine Signaling Pathways and Interactions 4
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 3
Cellular and Molecular Neuroscience
- Photoreceptor and optogenetics research 2
Ecology
- Bacteriophages and microbial interactions 2

Co-authors: Peter F. Johnson Richard C. Schwartz Simon C. Williams Allan Dillner Christopher Bebbington Geoffrey Yarranton Sergei A. Nedospasov Keith Brown
Cited by: Immunology Cancer Research Hematology
Journals: Blood (6 papers)Journal of Biological Chemistry (5 papers)Molecular and Cellular Biology (3 papers)
Partner nations: United States Australia France

In The Last Decade

Mark Baer

22 papers receiving 1.3k citations

Peers

Countries citing papers authored by Mark Baer

Since Specialization

Citations

This map shows the geographic impact of Mark Baer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Baer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Baer more than expected).

Fields of papers citing papers by Mark Baer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Baer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Baer. The network helps show where Mark Baer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Baer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Baer Line = papers co-authored together Mark Baer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Highly Productive Thermothelomyces heterothallica C1 Expression System as a Host for Rapid Development of Influenza Vaccines Vaccines ·Gábor Keresztes,Mark Baer,Mark R. Alfenito,Theo C. Verwoerd,Andriy Kovalchuk,Marilyn G. Wiebe,閔庚玹,Dhivya Govindasamy,Ronen Tchelet,Елена М. Климина,Gunnveig Grødeland,Mark Emalfarb	2022	4
2	Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment Cancer Research ·Mary E. Vail,Carmel Murone,Veronika Chvátalová,Linda Hii,Jennifer Berglund,Peter W. Janes,Fook-Thean Lee,Mark Baer,P Sanwaria,Christopher Bebbington,Geoffrey Yarranton,A. J. Cuerda,I. G. Vilesova,David Abramson,Glenn A. Cartwright,Andrew M. Scott,Martin Lackmann	2014	67
3	A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity Growth Factors ·Nenad Tomas̆ević,Kenneth R. Luehrsen,Mark Baer,P Sanwaria,David Martínez,J.C. Williams,Johanna Virstedt,Swathi Sujatha-Bhaskar,河村洋行,John Leung,شریف حمدی,Vladimir Shaydakov,Elsisabeth Siti Herini,Geoffrey Yarranton,Christopher Bebbington	2014	10
4	The eosinophil surface receptor epidermal growth factor–like module containing mucin-like hormone receptor 1 (EMR1): A novel therapeutic target for eosinophilic disorders Journal of Allergy and Clinical Immunology ·Fanny Legrand,Nenad Tomas̆ević,Olga Šimáková,Chyi‐Chia Richard Lee,Δέσποινα Χριστοπούλου,Mark Raffeld,Michelle Makiya,P Sanwaria,John Leung,Mark Baer,Geoffrey Yarranton,Irina Marić,Christopher Bebbington,Amy D. Klion	2014	52
5	GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia Blood ·Eric Padron,Jeffrey S. Painter,Sateesh Kunigal,Adam W. Mailloux,Kathy L. McGraw,F Leibundgut,Eun Hee Kim,Christopher Bebbington,Mark Baer,Geoffrey Yarranton,Jeffrey E. Lancet,Rami S. Komrokji,Omar Abdel‐Wahab,Alan F. List,Pearlie K. Epling‐Burnette	2013	108
6	Preclinical Characterization of KB003, a Novel Humaneered™ Monoclonal Anti-GM-CSF Antibody, Demonstrates That the GM-CSF Signaling Axis Is a Therapeutic Target in Chronic Myelomonocytic Leukemia (CMML) Blood ·Eric Padron,Jeffrey S. Painter,Adam W. Mailloux,Kathy L. McGraw,F Leibundgut,Christopher Bebbington,Mark Baer,Geoffrey Yarranton,Jeffrey E. Lancet,Rami S. Komrokji,Alan F. List,Pearlie K. Epling‐Burnette	2012	0
7	Antibody to Granulocyte Macrophage Colony–stimulating Factor Reduces the Number of Activated Tissue Macrophages and Improves Left Ventricular Function After Myocardial Infarction in a Rat Coronary Artery Ligation Model Journal of Cardiovascular Pharmacology ·Robert S. Kellar,瀧波慶和,Jiacheng Yao,Elizabeth Juneman,Nicholle M. Johnson,Robin Stokke Johansen,Maribeth Stansifer,Reza Arsanjani,Mark Baer,Christopher Bebbington,Michael Flashner,Geoffrey Yarranton,Steven Goldman	2011	10
8	GM-CSF Signaling Abnormalities in Chronic Myelomonocytic Leukemia Blood ·Eric Padron,Jeffrey S. Painter,Adam W. Mailloux,F Leibundgut,Christopher Bebbington,Mark Baer,Rami S. Komrokji,Alan F. List,Pearlie K. Epling‐Burnette	2011	2
9	A Recombinant Antibody to EphA3 with Pro-Apoptotic and Enhanced ADCC Activity Against Various Hematologic Malignancies Shows Selective Inhibition of Colony Formation From Long-Term Culture-Initiating Cells (LTC-ICs) In Primary Leukemia Samples Blood ·P Sanwaria,Mike Lara,Mark Baer,شریف حمدی,Nenad Tomas̆ević,David Martínez,Johanna Virstedt,Owel Sun Oh,Kenneth R. Luehrsen,J.C. Williams,John Leung,Alan F. List,Ling Zhang,Martin Lackmann,Andy Boyd,Andrew M. Scott,Daniela Cilloni,Geoffrey Yarranton,Christopher Bebbington	2010	6
10	High-resolution characterization of antibody fragment/antigen interactions using Biacore T100 Analytical Biochemistry ·Giuseppe A. Papalia,Mark Baer,Kenneth R. Luehrsen,C.M. Hinds Howell,Peter J. Flynn,David G. Myszka	2006	36
11	BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages Journal of Biological Chemistry ·Jovanović Snežana D.,Mark Baer,Howard A. Young,Estefanı́a Claudio,Keith Brown,Ulrich Siebenlist,Peter F. Johnson	2004	171
12	Regulation of CCAAT/Enhancer-binding Protein (C/EBP) Activator Proteins by Heterodimerization with C/EBPγ (Ig/EBP) Journal of Biological Chemistry ·亘浅野,Mark Baer,Terry D. Copeland,Richard C. Schwartz,Peter F. Johnson	2002	59
13	Generation of Truncated C/EBPβ Isoforms by in VitroProteolysis Journal of Biological Chemistry ·Mark Baer,Peter F. Johnson	2000	66
14	The C/EBP bZIP Domain Can Mediate Lipopolysaccharide Induction of the Proinflammatory Cytokines Interleukin-6 and Monocyte Chemoattractant Protein-1 Journal of Biological Chemistry ·Li Cui Zhang,Qiang Tian,Mark Baer,Chauncey J. Spooner,Simon C. Williams,Peter F. Johnson,Richard C. Schwartz	2000	86
15	Tumor Necrosis Factor Alpha Transcription in Macrophages Is Attenuated by an Autocrine Factor That Preferentially Induces NF-κB p50 Molecular and Cellular Biology ·Mark Baer,Allan Dillner,Richard C. Schwartz,Sally Salinas-Herrero,Sergei A. Nedospasov,Peter F. Johnson	1998	161
16	Autocrine Signals Control CCAAT/Enhancer Binding Protein β Expression, Localization, and Activity in Macrophages Blood ·Mark Baer,Simon C. Williams,Allan Dillner,Richard C. Schwartz,Peter F. Johnson	1998	44
17	Redundancy of C/EBPα, -β, and -δ in Supporting the Lipopolysaccharide-Induced Transcription of IL-6 and Monocyte Chemoattractant Protein-1 The Journal of Immunology ·محمود اردهامی,Mark Baer,Simon C. Williams,Peter F. Johnson,Richard C. Schwartz	1998	74
18	The Ability of C/EBPβ but Not C/EBPα To Synergize with an Sp1 Protein Is Specified by the Leucine Zipper and Activation Domain Molecular and Cellular Biology ·Ying‐Hue Lee,Simon C. Williams,Mark Baer,Esta Sterneck,Frank J. Gonzalez,Peter F. Johnson	1997	122
19	The role of conserved amino acids in substrate binding and discrimination by photolyase Journal of Biological Chemistry ·Mark Baer,Gwendolyn B. Sancar	1993	20
20	Photolyases from Saccharomyces cerevisiae and Escherichia coli Recognize Common Binding Determinants in DNA Containing Pyrimidine Dimers Molecular and Cellular Biology ·Mark Baer,Gwendolyn B. Sancar	1989	7

About Mark Baer

Mark Baer is a scholar working on Cancer Research, Immunology and Cellular and Molecular Neuroscience, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (6 papers), Cytokine Signaling Pathways and Interactions (4 papers), Acute Myeloid Leukemia Research (3 papers), Immune cells in cancer (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Photoreceptor and optogenetics research (2 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Immunology (485 citations), Cancer Research (277 citations) and Hematology (132 citations). Mark Baer has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Peter F. Johnson, Richard C. Schwartz, Simon C. Williams, Allan Dillner, Christopher Bebbington, Geoffrey Yarranton, Sergei A. Nedospasov, Keith Brown, Howard A. Young and Ulrich Siebenlist. Their work appears in journals such as Blood, Journal of Biological Chemistry, Molecular and Cellular Biology, Growth Factors and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact